6:32 am Alexion Pharma: European Commission grants orphan drug designation to Soliris (eculizumab) for prevention of delayed graft function after solid organ transplantation
View todays social media effects on ALXN
View the latest stocks trending across Twitter. Click to view dashboard
See who Alexion is hiring next, click here to view
